SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Intra-Cellular Therapies, Inc. Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia